Cancer Quality Results
Our Quality Results
Pennsylvania Health Care Quality Alliance (PHCQA) Report
2014 data to be publicly reported as of 1/1/2016
Radiation therapy is administered within one year for women receiving breast-conserving surgery for breast cancer.
LVH: 90.1%
LVH-M: 92.1%
Pa. Rate: 95.1%
US Rate: 92.2%
COC Standard: 90%
Combination chemotherapy is considered or administered within 4 months of diagnosis for women with hormone-receptor negative breast cancer.
LVH: 100%
LVH-M: 100%
Pa. Rate: 95.3%
US Rate: 92.4%
COC Standard: 90%
Tamoxifen (or equivalent drug therapy) is considered or administered within one year for women with hormone-receptor positive breast cancer.
LVH: 98.6%
LVH-M: 98.7%
Pa. Rate: 96.7%
US Rate: 92.5%
COC Standard: 90%
At least 12 regional lymph nodes are removed and examined for colon cancer patients who have had colon surgery.
LVH: 99%
LVH-M: 91.7%
Pa. Rate: 91.1%
US Rate: 91.2%
COC Standard: 80%
Chemotherapy is considered or administered within 4 months of diagnosis for patients with (lymph node positive) colon cancer.
LVH: 96.4%
LVH-M: 95%
Pa. Rate: 95%
US Rate: 89%
COC Standard: 90%